These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Mitochondrial disease and epilepsy. Kang HC; Lee YM; Kim HD Brain Dev; 2013 Sep; 35(8):757-61. PubMed ID: 23414619 [TBL] [Abstract][Full Text] [Related]
29. Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases. Hanna MG; Nelson IP Cell Mol Life Sci; 1999 May; 55(5):691-706. PubMed ID: 10379358 [TBL] [Abstract][Full Text] [Related]
30. Movement disorders in mitochondrial diseases. Tranchant C; Anheim M Rev Neurol (Paris); 2016; 172(8-9):524-529. PubMed ID: 27476418 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial encephalomyopathies: therapeutic approach. Dimauro S; Mancuso M; Naini A Ann N Y Acad Sci; 2004 Apr; 1011():232-45. PubMed ID: 15126300 [TBL] [Abstract][Full Text] [Related]
32. Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype. Morgan-Hughes JA; Sweeney MG; Cooper JM; Hammans SR; Brockington M; Schapira AH; Harding AE; Clark JB Biochim Biophys Acta; 1995 May; 1271(1):135-40. PubMed ID: 7599199 [TBL] [Abstract][Full Text] [Related]
33. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation. Fosslien E Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862 [TBL] [Abstract][Full Text] [Related]
34. Human mitochondrial diseases: answering questions and questioning answers. Howell N Int Rev Cytol; 1999; 186():49-116. PubMed ID: 9770297 [TBL] [Abstract][Full Text] [Related]
35. Sequence analysis of the complete mitochondrial genome in patients with mitochondrial encephaloneuromyopathies lacking the common pathogenic DNA mutations. Da Pozzo P; Cardaioli E; Radi E; Federico A Biochem Biophys Res Commun; 2004 Nov; 324(1):360-4. PubMed ID: 15465027 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis of the mitochondrial encephalomyopathies. Shanske S; DiMauro S Curr Opin Rheumatol; 1997 Nov; 9(6):496-503. PubMed ID: 9375278 [TBL] [Abstract][Full Text] [Related]
37. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Shidara Y; Yamagata K; Kanamori T; Nakano K; Kwong JQ; Manfredi G; Oda H; Ohta S Cancer Res; 2005 Mar; 65(5):1655-63. PubMed ID: 15753359 [TBL] [Abstract][Full Text] [Related]
38. [Mitochondrial encephalomyopathies starting in childhood and adolescence]. Castro-Gago M; Novo-Rodríguez MI; Eirís-Puñal J Rev Neurol; 1998 Apr; 26 Suppl 1():S61-71. PubMed ID: 9810592 [TBL] [Abstract][Full Text] [Related]
39. Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders. Uusimaa J; Remes AM; Rantala H; Vainionpää L; Herva R; Vuopala K; Nuutinen M; Majamaa K; Hassinen IE Pediatrics; 2000 Mar; 105(3 Pt 1):598-603. PubMed ID: 10699115 [TBL] [Abstract][Full Text] [Related]